The S-nitrosylation-mediated modification of p53 leads to altered DNA binding and associates with inactivity of p53 in human melanoma cells

被引：0
|
作者：
Qin, Yong [1 ]
Kwon, John [1 ]
Li, Li [2 ]
Rosenblatt, Kevin R. [3 ]
Zhang, Shuxing [1 ]
Chen, Lu [1 ]
Jayachandran, Gitanjali [1 ]
Grimm, Elizabeth A. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[3] Brown Fdn Inst Mol Med, Houston, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4988
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4988
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Human securin: a p53 mediated protooncogene
    Wu, Chang You
    Chao, Jui-I
    Chu, Hsueh-Liang
    Chang, Pei-Hsin
    Lo, Chiu-An
    Chao, Hsiu-Ming
    Chang, Chia-Ching
    FASEB JOURNAL, 2007, 21 (05): : A634 - A634
  • [22] ADP-ribosylation of wild-type p53 in vitro: Binding of p53 protein to specific p53 consensus sequence prevents its modification
    WesierskaGadek, J
    Schmid, G
    Cerni, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (01) : 96 - 102
  • [23] HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells
    Qu, Jianhui
    Lin, Jing
    Zhang, Shuhui
    Zhu, Zhi
    Ni, Canrong
    Zhang, Shunmin
    Gao, Hengjun
    Zhu, Minghua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (03) : 504 - 509
  • [24] TRANSACTIVATIONAL AND DNA-BINDING ABILITIES OF ENDOGENOUS P53 IN P53 MUTANT-CELL LINES
    PARK, DJ
    NAKAMURA, H
    CHUMAKOV, AM
    SAID, JW
    MILLER, CW
    CHEN, DL
    KOEFFLER, HP
    ONCOGENE, 1994, 9 (07) : 1899 - 1906
  • [25] Stimulation of p53 DNA binding by c-Abl requires the p53 c terminus and tetramerization
    Nie, Y
    Li, HH
    Bula, CM
    Liu, XA
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) : 741 - 748
  • [26] Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
    Michaelis, M.
    Rothweiler, F.
    Agha, B.
    Barth, S.
    Voges, Y.
    Loeschmann, N.
    von Deimling, A.
    Breitling, R.
    Doerr, H. Wilhelm
    Roedel, F.
    Speidel, D.
    Cinatl, J., Jr.
    CELL DEATH & DISEASE, 2012, 3 : e294 - e294
  • [27] Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
    M Michaelis
    F Rothweiler
    B Agha
    S Barth
    Y Voges
    N Löschmann
    A von Deimling
    R Breitling
    H Wilhelm Doerr
    F Rödel
    D Speidel
    J Cinatl
    Cell Death & Disease, 2012, 3 : e294 - e294
  • [28] WILD-TYPE ALTERNATIVELY SPLICED P53 - BINDING TO DNA AND INTERACTION WITH THE MAJOR P53 PROTEIN IN-VITRO AND IN CELLS
    WU, Y
    LIU, YG
    LEE, L
    MINER, Z
    KULESZMARTIN, M
    EMBO JOURNAL, 1994, 13 (20): : 4823 - 4830
  • [29] Arsenite inhibits p53 phosphorylation, DNA binding activity and p53 target gene p21expression
    Tang, Faqing
    Liu, Guangming
    He, Zhiwei
    Ma, Wei-Ya
    Bode, Ann M.
    Dong, Zigang
    CANCER RESEARCH, 2006, 66 (08)
  • [30] STRUCTURE AND POSTTRANSLATIONAL MODIFICATION OF THE HUMAN P53 PROTEIN
    APPELLA, E
    FISCELLA, M
    ZAMBRANO, N
    ULLRICH, SJ
    SAKAGUCHI, K
    SAKAMOTO, H
    LEWIS, MS
    LIN, D
    MERCER, WE
    ANDERSON, CW
    JOURNAL OF PROTEIN CHEMISTRY, 1994, 13 (05): : 499 - 500
12345